Outcomes and predictors of treatment response with sofosbuvir plus daclatasvir with or without ribavirin in Egyptian patients with genotype 4 hepatitis C virus infection

Outcomes and predictors of treatment response with sofosbuvir plus daclatasvir with or without ribavirin in Egyptian patients with genotype 4 hepatitis C virus infection

Ossama A Ahmed,1 Mohamed A Elsebaey,2 Mohamed Hassan A Fouad,1 Heba Elashry,3 Ahmed I Elshafie,1 Ahmed A Elhadidy,2 Noha E Esheba,2 Mohammed H Elnaggar,2 Shaimaa Soliman,4 Sherief Abd-Elsalam3 1Department of Internal Medicine, Ain Shams University, Faculty of Medicine, Cairo, Egypt; 2Department of I...

Full description

Bibliographic Details
Main Authors: Ahmed OA, Elsebaey MA, Fouad MHA, Elashry H, Elshafie AI, Elhadidy AA, Esheba NE, Elnaggar MH, Soliman S, Abd-Elsalam S
Format: Article
Language:English
Published: Dove Medical Press 2018-03-01
Series:Infection and Drug Resistance
Subjects:
Hepatitis C virus
genotype 4
sofosbuvir plus daclatasvir
sustained virologic response
Online Access:https://www.dovepress.com/outcomes-and-predictors-of-treatment-response-with-sofosbuvir-plus-dac-peer-reviewed-article-IDR

Internet

https://www.dovepress.com/outcomes-and-predictors-of-treatment-response-with-sofosbuvir-plus-dac-peer-reviewed-article-IDR

Similar Items